Sanofi | Competitive Intelligence Profile
Sanofi is a research and development-driven, AI-powered biopharmaceutical company headquartered in Paris, France, specializing in...
Sanofi is a research and development-driven, AI-powered biopharmaceutical company headquartered in Paris, France, specializing in vaccines, rare diseases, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare. It focuses on improving lives through innovative medicines and vaccines, with a portfolio that includes prescription drugs, generics, and over-the-counter products, and is known for flagship drugs like Dupixent.
🛍️ Sanofi Product and Pricing Intelligence →
📅 Sanofi Event Participations →
⚖️ Sanofi Regulatory Intelligence →
👔 Sanofi Management and Leadership Team →
⚔️ Sanofi Alternatives and Competitors →
💼 Sanofi Hiring and Layoffs →
🤝 Sanofi Partnerships, Clients and Vendors →
📈 Sanofi Financial Performance, Fundraising, M&A →
🛍️ Sanofi Product and Pricing Intelligence
Leverage product insights to define key product development milestones, guide go-to-market planning, build a robust product-market fit matrix, and perform in-depth SWOT analyses.
Harness pricing intelligence to support strategic pricing decisions, conduct competitive pricing analysis, and craft effective differential pricing strategies.
- Sanofi announced on February 2, 2026, that venglustat met the primary endpoint and three of four secondary endpoints in a phase 3 study for type 3 Gaucher disease, with Houman Ashrafian, PhD, head of research and development at Sanofi, noting it could make a difference for patients.
📅 Sanofi Event Participations
Stay updated on where your competitors are showing up—industry conferences, webinars, podcasts, and speaking engagements—to gauge their messaging, target audiences, and strategic focus. Discover how they’re positioning themselves in the market, what narratives they’re pushing, and which partnerships they’re cultivating. Use this intelligence to refine your own positioning, identify missed opportunities, and stay top-of-mind in your industry.
- Sanofi's President Takihiko Iwaya participated in the World Cancer Week 2026 session on patient engagement and AI, sharing AI use cases to support patient involvement.
- Sanofi holds a symposium in Liffey B on February 4 to examine finding haemostatic balance in an evolving treatment landscape, focusing on how treatment decisions adapt in practice.
⚖️ Sanofi Regulatory Intelligence
Monitor critical regulatory events—such as issued or revoked licenses, lawsuits, investigations, and court rulings—to understand the compliance posture and legal exposure of your rivals. Spot early warning signs of operational risk, delays, or reputational damage, and use these insights to fine-tune your market strategy, mitigate your own risk, or capitalize on competitor setbacks.
- Sanofi's investigational BTK inhibitor for wAIHA received Breakthrough Therapy Designation from the FDA and Orphan Drug designation in Japan on February 9.
- Sanofi's rilzabrutinib received breakthrough therapy designation in the US and orphan drug designation in Japan for treating warm autoimmune hemolytic anemia.
- The FDA issued a Complete Response Letter to Sanofi in December for its Tolebrutinib application, raising concerns that may not be easy to resolve.
👔 Sanofi Management and Leadership Team
Understand who’s steering your competitors by tracking changes in their management and leadership teams. Gain insights into strategic direction, leadership style, and organizational priorities based on executive backgrounds and hiring trends. Use this knowledge to anticipate competitive moves, tailor your sales or partnership approach, and benchmark against industry leaders.
-
Executive Director
-
Chief Financial Officer
[email protected] -
Chief Executive Officer[email protected]
-
Former Chief Financial Officer[email protected]
-
Chief Technology Officer & Global Head of Research & Biomarkers, mRNA Center of Excellence
-
CFO & Managing Director Finance
⚔️ Sanofi Alternatives and Competitors
Identify the competitors of your competitors to uncover indirect threats, emerging disruptors, and untapped opportunities. Understand the broader competitive ecosystem, spot white space in the market, and gain strategic context that helps you position more effectively. These insights sharpen your market intelligence and reveal angles others often overlook.
- Novartis |
- Novo Nordisk |
- GSK |
- Takeda Pharmaceutical |
- argenex |
- AstraZeneca |
- Pfizer |
- Merck |
- Johnson & Johnson |
- AbbVie |
- Daiichi Sankyo |
- Amgen |
- Teva |
- Mylan |
- Sandoz |
- Roche |
- Abbott |
- Lilly |
- Medtronic |
- Bristol-Myers Squibb |
- Gilead Sciences |
- Celgene |
- Genentech |
- GLOBAL BLOOD THERAPEUTICS |
- Eli Lilly
💼 Sanofi Hiring and Layoffs
Track key workforce changes—new hires, leadership shifts, and layoffs—to spot strategic organizational moves. Identify rising competitors, uncover shifts in company direction, and seize opportunities to attract top talent or engage new decision-makers. Use these insights to refine your recruitment strategy and build stronger business relationships.
- Azhar Ravji joined Sanofi as Associate Director, Value & Access – Vaccines in the United States, previously serving as Interdisciplinary Scientist at Biomedical Advanced Research and Development Authority (BARDA).
- Shihai Lu joined Sanofi as Director Biostatistics in the United States, previously Associate Director at Takeda.
- Christopher Bayles joined Sanofi as Senior Director, AI & Reporting Analytics for Patient Services in the United States, previously Executive Director, Pelacarsen and Lp(a) Insights & Analytics at Novartis.
🤝 Sanofi Partnerships, Clients and Vendors
Monitor new partnerships, client wins, and vendor relationships to understand where your competitors are gaining traction. Spot emerging alliances, evaluate ecosystem shifts, and identify potential partners or prospects early. These insights help you refine your sales strategy, anticipate market movements, and stay one step ahead in a dynamic competitive landscape.
- Sanofi signed a Memorandum of Understanding with National Unified Procurement Company NUPCO to strengthen healthcare supply resilience in the Kingdom.
- Sanofi signed a memorandum of understanding with Nobco to enhance drug planning and supply efficiency, ensure medical supply continuity, support reliance on local pharmaceutical products, and exchange expertise.
- Sanofi's joint initiative with partner OAO to embed AI-first transformation using AI agents across the organization was recognized by the World Economic Forum as part of the MINDS Programme.
📈 Sanofi Financial Performance, Fundraising, M&A
Track competitors’ financial performance, fundraising rounds, and M&A activity to assess their growth trajectory and strategic focus. Uncover signals of expansion, market entry, or consolidation, and benchmark your position accordingly. Use these insights to inform investor conversations, identify acquisition opportunities, and fine-tune your competitive strategy.
- Sanofi CEO Paul Hudson doubled down on his support for vaccine development despite a 2.5% dip in vaccine sales in 2025.
- Sanofi announced a Euro 1 billion share buyback programme for 2026, starting February 3.
People also viewed
- Coty |
- Millennium |
- Parsley Health |
- HelloPrint |
- FreshRSS |
- elink |
- Mary Kay |
- Feedly |
- Sourced Up |
- Estée Lauder |
- Kenvue |
Ready to outsmart the competition? RivalSense cuts through the clutter of generic tools like Google Alerts, delivering laser-focused competitive intelligence without the noise. Track competitors’ every move—website changes, product updates, social media buzz, news mentions, and regulatory shifts—all in one sleek platform. Uncover pricing strategies, decode market trends, and gain actionable insights to fuel your business strategy. No more guesswork. Just power.
Join thousands of forward-thinking teams who trust RivalSense to automate their competitive monitoring and turn data into domination. Start your FREE trial today—no credit card needed—and see why staying ahead has never been this easy. Your competitors won’t know what hit them.
Outthink. Outpace. Outperform. #RivalSense